Standout Papers

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and cli... 1997 2026 2006 2016 622
  1. Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials (1997)
    E.S. Newlands, M. F. G. STEVENS et al. Cancer Treatment Reviews

Immediate Impact

1 by Nobel laureates 12 from Science/Nature 90 standout
Sub-graph 1 of 21

Citing Papers

Transcription–replication conflicts underlie sensitivity to PARP inhibitors
2024 StandoutNature
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
2020 Standout
13 intermediate papers

Works of C. Brock being referenced

Phase I trial of temozolomide using an extended continuous oral schedule.
1998
Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials
1997 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
C. Brock 228 564 640 423 31 1.7k
Günther Stockhammer 319 814 842 330 43 2.2k
Carl P. Boesel 88 439 546 272 36 1.6k
L. S. Lashford 235 680 937 384 47 1.9k
Wilfried J. Graveland 144 381 336 522 27 1.7k
Eric T. Shinohara 289 755 298 721 78 2.2k
R. Rampling 441 551 1302 666 29 2.1k
Barry L. Dowell 206 509 165 791 48 1.9k
James G. Douglas 58 339 349 348 48 1.6k
Markus Hutterer 209 270 907 363 47 1.6k
Julian D. Down 313 532 283 468 50 2.0k

All Works

Loading papers...

Rankless by CCL
2026